Zobrazeno 1 - 10
of 35
pro vyhledávání: '"Mariele Goebeler"'
Autor:
Martina Fröhlich, Hermann Kneitz, Stefan Fröhling, Valerie Glutsch, Heinz Kutzner, Andreas Rosenwald, Katja Maurus, Sabine Roth, Daniel Hübschmann, Silke Appenzeller, Bastian Schilling, Mathias T. Rosenfeldt, Hanno Glimm, Mariele Goebeler, Lino Möhrmann, David Schrama, A. Stenzinger, C Kosnopfel, Elena Gerhard-Hartmann
Publikováno v:
British Journal of Dermatology. 186:553-563
Background Epithelioid haemangioma (EH) arising from the skin is a benign vascular tumour with marked inflammatory cell infiltration, which exhibits a high tendency to persist and frequently recurs after resection. So far, the underlying pathogenesis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::cfe832045cf2745795f54a200b2aae5b
https://doi.org/10.1111/bjd.20869
https://doi.org/10.1111/bjd.20869
Autor:
Lutz P. Müller, Michael Hallek, Ursula Vehling-Kaiser, Werner Freier, Andreas Bühler, Georg Hopfinger, Kirsten Fischer, I Blau, H Schimke, Michael J. Eckart, C M Wendtner, Barbara Eichhorst, Harald Fuss, Bertold Emmerich, Raymonde Busch, F. Hartmann, Hartmut Döhner, Mariele Goebeler, Wolfgang Abenhardt, Martin Bentz, Ulrich Jäger, Jasmin Bahlo, H J Hurtz, S. Stilgenbauer, Manuela Hoechstetter, Dirk Winkler
Publikováno v:
Leukemia. 31:2833-2837
Early, risk-adapted treatment with fludarabine in Binet stage A chronic lymphocytic leukemia patients: results of the CLL1 trial of the German CLL study group
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1a6755c37d0c1dc17d6b9bfe33602d28
https://doi.org/10.1038/leu.2017.246
https://doi.org/10.1038/leu.2017.246
Autor:
Mascha Binder, Mariele Goebeler, Sebastian Böttcher, Peter Nollau, Anna-Katharina Kurze, Ralf C. Bargou, Anna Brandt, Friederike Braig, Hans-Peter Tony, Thomas Bumm
Publikováno v:
Blood. 129:100-104
The CD19 antigen is a promising target for immunotherapy of acute lymphoblastic leukemia (ALL), but CD19- relapses remain a major challenge in about 10% to 20% of patients. Here, we analyzed 4 CD19- ALL relapses after treatment with the CD19/CD3 bisp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f4d9a4f7f9f57f231bd03882d21630c
https://doi.org/10.1182/blood-2016-05-718395
https://doi.org/10.1182/blood-2016-05-718395
Publikováno v:
European Journal of Cancer. 101:284-286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::ecd29bec586b10135c9ee62507f8b608
https://doi.org/10.1016/j.ejca.2018.06.014
https://doi.org/10.1016/j.ejca.2018.06.014
Autor:
E. Eigendorff, Christian Dietz, Cornelius F. Waller, G. Freunek, Martin C. Müller, Thomas Illmer, Mahon Fx, Andreas Neubauer, Florian Finkernagel, T H Brümmendorf, Joelle Guilhot, Stefan Hanzel, Rüdiger Hehlmann, Cornelia Brendel, Sabrina Inselmann, Magdalena Huber, S K Metzelder, Jolanta Dengler, Andreas Burchert, Yanfeng Wang, Susanne Saussele, Markus Pfirrmann, Thoralf Lange, Mariele Goebeler, Regina Herbst, Andreas Hochhaus, Christin Schütz
Publikováno v:
Leukemia. 32(4)
It is unknown, why only a minority of chronic myeloid leukemia (CML) patients sustains treatment free remission (TFR) after discontinuation of tyrosine kinase inhibitor (TKI) therapy in deep molecular remission (MR). Here we studied, whether expressi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::beddfa6becb05a7c039ad92cc111fc2f
https://pubmed.ncbi.nlm.nih.gov/28074067
https://pubmed.ncbi.nlm.nih.gov/28074067
Autor:
Andreas Rosenwald, Katja Maurus, Silke Appenzeller, Marion Wobser, Mariele Goebeler, Eva Geissinger, Sabine Roth
Publikováno v:
European Journal of Cancer. 119:S14-S15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9abcb98593cb920cb31ecc7944869013
https://doi.org/10.1016/s0959-8049(19)30549-0
https://doi.org/10.1016/s0959-8049(19)30549-0
Autor:
Hermann Kneitz, Sandrine Benoit, Anja Gesierich, Bastian Schilling, V. Behle, Mariele Goebeler, V. Haug
Publikováno v:
British Journal of Dermatology. 179:993-994
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cc87b5cdcb8c278eb94d685754ea89e4
https://doi.org/10.1111/bjd.16780
https://doi.org/10.1111/bjd.16780
Autor:
Sabine Roth, Katja Maurus, Andreas Rosenwald, Hermann Kneitz, J. Olk, Marion Wobser, Mariele Goebeler, Eva Geissinger
Publikováno v:
European Journal of Cancer. 119:S16
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::94b7897a1b3c7985674a45c06e8a18d7
https://doi.org/10.1016/s0959-8049(19)30553-2
https://doi.org/10.1016/s0959-8049(19)30553-2
Autor:
Andreas Viardot, Youssef Hijazi, Dieter Hoelzer, Svenja Neumann, Nicola Gökbuget, Dirk Nagorsen, Max S. Topp, Peter Kufer, Andreas Wolf, Evelyn Degenhard, Gerhard Zugmaier, Monika Brüggemann, Matthias Stelljes, Mariele Goebeler, Matthias Klinger, Christian Brandl, Ralf C. Bargou, Patrick A. Baeuerle
Publikováno v:
Blood. 119:6226-6233
T cell–engaging CD19/CD3-bispecific BiTE Ab blinatumomab has shown an 80% complete molecular response rate and prolonged leukemia-free survival in patients with minimal residual B-lineage acute lymphoblastic leukemia (MRD+ B-ALL). Here, we report t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::01a8b4be79d0a2f81f0667061d7cb47e
https://doi.org/10.1182/blood-2012-01-400515
https://doi.org/10.1182/blood-2012-01-400515
Autor:
Christoph Losem, Klaus Blumenstengel, Norbert Gattermann, Rudolf Schlag, Andrea Jarisch, Maria Procaccianti, Oliver Leismann, Mariele Goebeler, Matthias Groschek, Alexia Junkes, Ulrich Germing
Publikováno v:
European Journal of Haematology
EXtend and eXjange were prospective, 1-yr, non-interventional, observational, multicentre studies that investigated deferasirox, a once-daily oral iron chelator, in iron-overloaded chelation-naïve and prechelated patients with myelodysplastic syndro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a97b67e19435eab8c544d3c51989f08a
https://doi.org/10.1111/j.1600-0609.2011.01726.x
https://doi.org/10.1111/j.1600-0609.2011.01726.x